tiprankstipranks
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market
CMPX
Compass Therapeutics
RESEARCH TOOLSreports

Compass Therapeutics (CMPX) Stock News & Sentiment

490 Followers
Compass Therapeutics (CMPX): Favorable Risk‑Reward Ahead of Pivotal Tovecimig Data in Biliary Tract Cancer
Premium
Ratings
Compass Therapeutics (CMPX): Favorable Risk‑Reward Ahead of Pivotal Tovecimig Data in Biliary Tract Cancer
4d ago
CMPX
Buy Rating on Compass Therapeutics: Anticipating Pivotal Tovecimig Data as a Key Value Inflection Point in Advanced Biliary Tract Cancer
Premium
Ratings
Buy Rating on Compass Therapeutics: Anticipating Pivotal Tovecimig Data as a Key Value Inflection Point in Advanced Biliary Tract Cancer
11d ago
CMPX
CMPX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CMPX Upcoming Earnings Report: What to Expect?
1M ago
CMPX
Buy Rating on Tovecimig Driven by Early Efficacy Signals and Differentiated Risk–Benefit Profile in Biliary Tract Carcinoma
Premium
Ratings
Buy Rating on Tovecimig Driven by Early Efficacy Signals and Differentiated Risk–Benefit Profile in Biliary Tract Carcinoma
2M ago
CMPX
Compass Therapeutics Moves CTX-10726 Into the Clinic: What Early Investors Should Know
Premium
Company Announcements
Compass Therapeutics Moves CTX-10726 Into the Clinic: What Early Investors Should Know
2M ago
CMPX
3 Strong Buy Stocks With 100%+ Upside, According to Top Analysts, 2/16/2026
Premium
Market News
3 Strong Buy Stocks With 100%+ Upside, According to Top Analysts, 2/16/2026
2M ago
BTDR
CMPX
Compass Therapeutics: Strengthening Clinical Pipeline and 2026 Milestones Underscore Buy Rating and Upside Potential
Premium
Ratings
Compass Therapeutics: Strengthening Clinical Pipeline and 2026 Milestones Underscore Buy Rating and Upside Potential
3M ago
CMPX
More CMPX News >

CMPX News on the Web

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Guardant Health (GH) and Compass Therapeutics (CMPX)
TipRanks News
Neutral
Compass Therapeutics (CMPX): Favorable Risk‑Reward Ahead of Pivotal Tovecimig Data in Biliary Tract Cancer
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Bicara Therapeutics Inc. (BCAX) and Compass Therapeutics (CMPX)
TipRanks News
Bullish
Buy Rating on Compass Therapeutics: Anticipating Pivotal Tovecimig Data as a Key Value Inflection Point in Advanced Biliary Tract Cancer
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Compass Therapeutics (CMPX) and Talphera (TLPH)
TipRanks News
Bullish
Compass Therapeutics (CMPX) Receives a Buy from Guggenheim
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CMPX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMPX’s Media Buzz Sentiment?
2 articles about CMPX were published this week. In an average week, 2 articles are published.
    What is CMPX’s weekly average amount of articles?
    In an average week, 2 articles about CMPX are published.
      What is CMPX’s News Sentiment?
      100% of articles about CMPX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week